Galaxy银河|澳门官网·登录入口

客户发表文献

至今，GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次，处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果，再次证明GenScript 有能力帮助业内科学家Make research easy.

页码: 1/1 每页显示数量

Selective and noncovalent targeting of RAS mutants for inhibition and degradation

Authors: Kai Wen Teng, Steven T Tsai, Takamitsu Hattori, Carmine Fedele, Akiko Koide, Chao Yang, Xuben Hou, Yingkai Zhang, Benjamin G Neel, John P O'Bryan, Shohei Koide

Journal: Nat Commun

PubMed ID: 33976200

Doi: 10.1038/s41467-021-22969-5

Products & Services: Catalog Antibody

New monoclonal antibodies that recognize an unglycosylated, conserved, extracellular region of CD44 in vitro and in vivo, and can block tumorigenesis

Authors: Daniel F Lusche, Deborah J Wessels, Ryan J Reis, Cristopher C Forrest, Alexis R Thumann, David R Soll

Journal: PLoS ONE

PubMed ID: 33891595

Doi: 10.1371/journal.pone.0250175

Products & Services: Stable Cell Lines

Expression of the small cysteine-rich protein SCR96 from Phytophthora cactorum in mammalian cells: phytotoxicity and exploitation of its polyclonal antibody

Authors: Huang SX,, Zhang ZH,, Liu W,, Tao H,, Zhang Y,, Shi NX,, Zhu F,, Ji ZL,, Chen XR,.